HT
HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $221.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 39.18%
Rev. growth 30.79%
FCF growth N/A
Profitability
10 /100
Weak Op. margin 327.19%
Gross margin 28.18%
FCF margin 289.51%
Quality
6 /100
Poor Asset turnover 0.36x
ROIC 151.08%
ROA 121.47%
Debt
59 /100
Moderate Int. coverage -24.19x
Debt/Equity 1.55x
Net debt/EBITDA 0.19x
Stability
40 /100
Moderate EPS volatility 14.49%
Beta 2.96x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na HTGMQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John L. Lubniewski
Employees
53
Headquarters
Tucson
Nadcházející události
13 LIS
Earnings
Upcoming earnings report